Literature DB >> 16961424

Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.

Amy F T Arnsten1.   

Abstract

Neuropsychological and imaging studies have shown that attention-deficit/hyperactivity disorder (ADHD) is associated with alterations in prefrontal cortex (PFC) and its connections to striatum and cerebellum. Research in animals, in combination with observations of patients with cortical lesions, has shown that the PFC is critical for the regulation of behavior, attention, and affect using representational knowledge. The PFC is important for sustaining attention over a delay, inhibiting distraction, and dividing attention, while more posterior cortical areas are essential for perception and the allocation of attentional resources. The PFC in the right hemisphere is especially important for behavioral inhibition. Lesions to the PFC produce a profile of distractibility, forgetfulness, impulsivity, poor planning, and locomotor hyperactivity. The PFC is very sensitive to its neurochemical environment, and optimal levels of norepinephrine and dopamine are needed for proper PFC control of behavior and attention. Recent electrophysiologic studies in animals suggest that norepinephrine enhances "signals" through postsynaptic alpha2A-adrenoceptors in PFC, while dopamine decreases "noise" through modest levels of D1-receptor stimulation. Blockade of alpha2-receptors in the monkey PFC re-creates the symptoms of ADHD, resulting in impaired working memory, increased impulsivity, and locomotor hyperactivity. Genetic alterations in catecholamine pathways may contribute to dysregulation of PFC circuits in this disorder. Stimulant medications may have some of their therapeutic effects by increasing endogenous stimulation of alpha2A-adrenoceptors and dopamine D1-receptors in the PFC, optimizing PFC regulation of behavior and attention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16961424

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  106 in total

1.  Clonidine improves attentional and memory components of delayed response performance in a model of early Parkinsonism.

Authors:  J S Schneider; J P Tinker; E Decamp
Journal:  Behav Brain Res       Date:  2010-03-27       Impact factor: 3.332

2.  Prioritization of candidate genes for attention deficit hyperactivity disorder by computational analysis of multiple data sources.

Authors:  Suhua Chang; Weina Zhang; Lei Gao; Jing Wang
Journal:  Protein Cell       Date:  2012-07-10       Impact factor: 14.870

3.  Neural correlates of speeded as compared with delayed responses in a stop signal task: an indirect analog of risk taking and association with an anxiety trait.

Authors:  Chiang-shan Ray Li; Herta H-A Chao; Tien-Wen Lee
Journal:  Cereb Cortex       Date:  2008-08-04       Impact factor: 5.357

Review 4.  Effects of normal aging on prefrontal area 46 in the rhesus monkey.

Authors:  Jennifer Luebke; Helen Barbas; Alan Peters
Journal:  Brain Res Rev       Date:  2009-12-11

5.  Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder.

Authors:  Moon-Soo Lee; Jae-Won Yang; Young-Hoon Ko; Changsu Han; Seung-Hyun Kim; Min-Soo Lee; Sook-Haeng Joe; In-Kwa Jung
Journal:  Child Psychiatry Hum Dev       Date:  2007-08-31

6.  Potential contribution of dopaminergic gene variants in ADHD core traits and co-morbidity: a study on eastern Indian probands.

Authors:  Subhamita Maitra; Kanyakumarika Sarkar; Paramita Ghosh; Arijit Karmakar; Animesh Bhattacharjee; Swagata Sinha; Kanchan Mukhopadhyay
Journal:  Cell Mol Neurobiol       Date:  2014-03-02       Impact factor: 5.046

Review 7.  Methylphenidate and the juvenile brain: enhancement of attention at the expense of cortical plasticity?

Authors:  Kimberly R Urban; Wen-Jun Gao
Journal:  Med Hypotheses       Date:  2013-09-17       Impact factor: 1.538

8.  Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex.

Authors:  Lori A Newman; Jenna Darling; Jill McGaughy
Journal:  Psychopharmacology (Berl)       Date:  2008-06-22       Impact factor: 4.530

9.  Methylphenidate treatment leads to abnormalities on krebs cycle enzymes in the brain of young and adult rats.

Authors:  Gislaine Z Réus; Giselli Scaini; Camila B Furlanetto; Meline O S Morais; Isabela C Jeremias; Lis Mairá Mello-Santos; Karolina V Freitas; João Quevedo; Emilio L Streck
Journal:  Neurotox Res       Date:  2013-02-20       Impact factor: 3.911

10.  Remediation of attentional dysfunction in rats with lesions of the medial prefrontal cortex by intra-accumbens administration of the dopamine D(2/3) receptor antagonist sulpiride.

Authors:  Marie A Pezze; Jeffrey W Dalley; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2008-11-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.